← Leaderboards
Robert M Conry
University Of Alabama At Birmingham
$882,302
Attributed
$882,302
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$882,302 · 6
By mechanism
R01$823,244 · 1
M01$59,058 · 4
P50$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Kirby I Bland$6,784,098
- David T Curiel$31,690,411
- Richard W Compans$30,337,837
- Etty N. Benveniste$18,164,533
- Polly Roy$6,105,431
Others in their field
Top investigators on “Clinical Trial Phase I”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Lawrence Corey · Fred Hutchinson Cancer Center$674,722,986
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$549,289,302
- Barton F Haynes · Duke University$532,133,792
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$407,280,377
Research focus
Clinical Trial Phase IHuman Therapy EvaluationClinical ResearchNeoplasm /Cancer ImmunotherapyHuman SubjectNeoplasm /Cancer VaccineMetastasisPolynucleotidesVector VaccineMelanomaDrug Screening /EvaluationCarcinoembryonal AntigenT LymphocytePlasmidsColony Stimulating FactorActive ImmunizationChimeric ProteinsBreast NeoplasmsDosageComplementary DnaCd40 MoleculeInterleukin 4Cancer PreventionHeat Shock Proteins
Grant awards (10)
POLYNUCLEOTIDE VACCINE STRATEGIES FOR MELANOMA$282,563
R01 · FY2002 · CA
POLYNUCLEOTIDE VACCINE THERAPY OF BREAST CANCER$0
P50 · FY2002 · CA
POLYNUCLEOTIDE VACCINE STRATEGIES FOR MELANOMA$274,335
R01 · FY2001 · CA
POLYNUCLEOTIDE VACCINE THERAPY OF BREAST CANCER$0
P50 · FY2001 · CA
POLYNUCLEOTIDE VACCINE STRATEGIES FOR MELANOMA$266,346
R01 · FY2000 · CA
POYLNUCLEOTIDE ANTI TUMOR IMMUNIZATION TO HUMAN CEA IN METASTIC COLORECTAL CANCER$29,529
M01 · FY2000 · RR
ALVAC HIL2 INTRATUMORALLY IN SURGICALLY INCURABLE MELANOMA$29,529
M01 · FY2000 · RR
POLYNUCLEOTIDE VACCINE THERAPY OF BREAST CANCER$0
P50 · FY2000 · CA
IMMUNIZATION OF COLORECTAL CANCER PATIENTS WITH ONCOVAX-CLB$0
M01 · FY2000 · RR
TRIAL OF ANTIIDIOTYPIC MAB VACCINE 4B5 IN MELANOMA$0
M01 · FY2000 · RR